AleAnna, Inc. (ANNA)
| Market Cap | 564.60M |
| Revenue (ttm) | 648,328 |
| Net Income (ttm) | -162.45M |
| Shares Out | 66.55M |
| EPS (ttm) | -609.57 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,089 |
| Open | 8.75 |
| Previous Close | 8.78 |
| Day's Range | 8.48 - 9.00 |
| 52-Week Range | 5.82 - 18.70 |
| Beta | 0.20 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About ANNA
AleAnna, Inc. focuses on the exploration and production of natural gas resource properties in Italy. It is also involved in the renewable natural gas development business; and holds working interests in the biogas plants. The company was founded in 2007 and is headquartered in Dallas, Texas. [Read more]
Financial Performance
Financial StatementsNews
AleAnna Announces Signing of Gas Sale Contract with Shell Energy Europe
AleAnna Secures A Contract To Sell Its Gas To Shell Energy Europe Ltd, A Leading Natural Gas, Power And Environmental Trading Company Across European Markets AleAnna has signed a multi-year gas sales ...
AleAnna, Inc. Announces Completion of Several Major Milestones for its Renewable Natural Gas (RNG) Business
DALLAS and ROME, Dec. 18, 2024 (GLOBE NEWSWIRE) -- AleAnna, Inc., (“AleAnna” or the “Company”) (Nasdaq: ANNA), today announced the completion of a series of initiatives through which the Company has e...
BRS Resources Announces Update on AleAnna Energy, LLC
Vancouver, British Columbia--(Newsfile Corp. - December 16, 2024) - BRS RESOURCES LTD. (CSE: BRS) (the "Company" or "BRS"), a mineral exploration company, is pleased to provide an update on its member...
HDL Therapeutics to Go Public in Merger with Swiftmerge Acquisition Corp.
NEW YORK & VERO BEACH, Fla.--(BUSINESS WIRE)---- $ipo #Consumer--HDL Therapeutics, Inc. (“HDL Therapeutics”), a privately held commercial stage biotech company with an FDA-approved cardiovascular ther...
HDL Therapeutics Inc Plans to Become Publicly Traded via a Business Combination With $225 Million Swiftmerge (NASDAQ: IVCP) With Goal to Transform Cardiovascular Disease Treatment
NEW YORK & VERO BEACH, Fla.--(BUSINESS WIRE)---- $health #Consumer--NASDAQ IVCP Swiftmerge Acquisition Corp (“Swiftmerge”), a $225 million innovative healthcare investment corporation and a special pu...